07:29 AM EDT, 09/23/2024 (MT Newswires) -- Matthew J Singleton, Director, on September 20, 2024, sold 10,300 shares in Viking Therapeutics ( VKTX ) for $715,850. Following the Form 4 filing with the SEC, Singleton has control over a total of 9,500 shares of the company, with 9,500 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1607678/000095017024108577/xslF345X05/ownership.xml

Price: 70.86, Change: +0.39, Percent Change: +0.55